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A possible interaction between glucocorticoids and estrogen-induced increases in brain-derived-neurotrophic factor (BDNF)
expression in enhancing depressive-like behaviour has been documented. Here we evaluated the effects of Tualang honey, a
phytoestrogen, and 17𝛽-estradiol (E2) on the depressive-like behaviour, stress hormones, and BDNF concentration in stressed
ovariectomised (OVX) rats. The animals were divided into six groups: (i) nonstressed sham-operated control, (ii) stressed sham-
operated control, (iii) nonstressed OVX, (iv) stressed OVX, (v) stressed OVX treated with E2 (20𝜇g daily, sc), and (vi) stressed
OVX treated with Tualang honey (0.2 g/kg body weight daily, orally). Two months after surgery, the animals were subjected to
social instability stress procedure followed by forced swimming test. Struggling time, immobility time, and swimming time were
scored. Serum adrenocorticotropic hormone (ACTH) and corticosterone levels, and the BDNF concentration were determined
using commercially available ELISA kits. Stressed OVX rats displayed increased depressive-like behaviour with significantly
increased serum ACTH and corticosterone levels, while the BDNF concentration was significantly decreased compared to other
experimental groups. These changes were notably reversed by both E2 and Tualang honey. In conclusion, both Tualang honey and
E2 mediate antidepressive-like effects in stressed OVX rats, possibly acting via restoration of hypothalamic-pituitary-adrenal axis
and enhancement of the BDNF concentration.
1. Introduction
Brain-derived-neurotrophic factor (BDNF) is one of several
endogenous proteins that play a critical role in the sur-
vival, maintenance, and growth of central and peripheral
neurons [1]. Importantly, dysfunction of BDNF may play a
role in the pathophysiology of various brain diseases such
as Huntington’s disease [2] and Alzheimer’s disease [3].
Reduction in BDNF levels has also been indicated in various
mental disorders [4–6] including depression [7, 8].Decreased
expression of BDNF contributes to hippocampal atrophy
and neuronal loss in experimental animals [9] and further
evidenced by decreased hippocampal volume in depressed
patients [10, 11]. Chronic antidepressant treatment induces
increases in BDNF level in the hippocampus of rodents [12]
and tree shrew [13].
Low ovarian estrogen level increases the susceptibility to
depressive disorders in postmenopausal women [4, 6, 14].
Estrogen is widely reported to have antidepressive effects as
shown by both human [15, 16] and animal studies [17, 18]
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and has been suggested as a potential treatment for depressed
mood during the postmenopausal period. Several studies
demonstrate that estrogen exerts direct modulatory effects
on BDNF [19–21]. As upregulation of BDNF is putatively
involved in the beneficial effects of several antidepressants,
further investigation concerning the detailed mechanisms
underlying the hormonal dependent production of BDNF is
critical. An earlier study by Sohrabji et al. [22] showed that
estrogen regulates the expression of BDNF via the estrogen
response element on the BDNF gene. However, the detailed
mechanisms concerning steroid hormone-stimulated intra-
cellular signaling and how this regulates BDNF dynamics
remain to be elucidated [23].
Persistent increase in glucocorticoids after prolonged
exposure to stress may cause extensive damage to the CNS
[24], triggering the onset of depression [18]. Since both BDNF
and glucocorticoids may be involved in neuronal function as
well as the pathophysiology of depression, a possible crosstalk
between BDNF and glucocorticoid function has been pro-
posed as one of the mechanisms for depression. Moreover,
a large number of preclinical and clinical studies provide evi-
dence supporting the association between stress/depression
and hippocampal abnormalities. These include decreased
hippocampal neurogenesis as a result of stress conditions
[24], its increase after antidepressant treatment [25], and
reduction of hippocampal volume in depressed patients [26].
In addition, suppression of hippocampal neurogenesis due to
hypothalamic-pituitary-adrenal axis (HPA) hyperactivity is
assumed to be one of the major pathways for mood disorders
including depression [27].
It is possible that depressive symptoms seen in post-
menopausal women with social stress to some extent result
from alteration in the BDNF expression and production.
However, during the past few years,manywomen anddoctors
have revised their opinions of hormone replacement therapy
(HRT) for menopausal depressive symptoms [28] and a
substantial number of women have discontinued HRT use
because of side effects [29].Themain side effects of estrogen-
replacement therapy are withdrawal bleeding, bloating, pre-
menstrual irritability, lower abdominal cramps, and breast
tenderness [29, 30]. Althoughmany of these troublesome side
effects can be managed by adjusting the dose or changing
the source of the estrogen or progestin components, post-
menopausal women view withdrawal bleeding as the most
negative factor [31] influencing their decision to refuse using
HRT.
Tualang honey is a multifloral honey produced by the
rock bee species (Apis dorsata), which builds hives high up
in the branches of Tualang tree (Koompassia excelsa). In
Malaysia, the honey is used traditionally as a health and
antiageing supplement [32]. Recently, our research reported
that Tualang honey, a phytoestrogen, improved memory
performance in postmenopausal women [33] and stressed
ovariectomised (OVX) rats [34], comparable to those receiv-
ing 17𝛽-estradiol (E2) treatment.This study therefore aims to
evaluate the possible relationship between the antidepressive-
like effects of Tualang honey and E2 and BDNF concentration
in stressed OVX rat model.
2. Material and Methods
2.1. Animal. Adult female Sprague Dawley rats aged 8 weeks
old with body weight of 200 ± 20 g were obtained from
the Animal Research and Service Centre (ARASC), Health
Campus, Universiti Sains Malaysia (USM), Malaysia. All rats
were housed in polypropylene cages (40×25×16 cm), exposed
to 12 hr light-dark cycles, maintained at room temperature
of 23∘C, and fed with pellet diet and water ad libitum.
Rats’ body weights were recorded daily throughout the
study. The rats were randomly divided into six groups of
10 rats in each group as follows: nonstressed sham-operated
control, stressed sham-operated control, nonstressed OVX,
stressed OVX, stressed OVX treated with 17𝛽-estradiol, and
stressed OVX treated with Tualang honey. The experimen-
tal protocol for this study was approved by the Animal
Research Ethics Committee of USM (USM/Animal Ethics
Approval/2011/(64)(272)), in accordance with the interna-
tionally accepted principles for laboratory animal use and
care.
2.2. Surgical Procedure. The animals were either ovariec-
tomised or sham-operated under anaesthesia (90mg/kg
ketamine and 5mg/kg xylazine, intraperitoneally). Following
anaesthesia, the animal’s abdominal fur was shaved and the
area carefully cleaned using chlorhexidine scrub and ethanol
70%. Immediately, a small midline incision (2 cm) was made
on the dorsal area of lumbar vertebrae 3–5. A high degree of
asepsis wasmaintained throughout the surgery. After surgery,
the animals were left under an overhead light source for one
hour to avoid hypothermia. Following surgical procedure,
the animals were given postoperative care by isolating each
animal in a clean cage for 10 days to avoid any infighting
that could cause bleeding or poor healing. After 10 days of
postoperative care, the rats were housed in groups of three
per cage and left for two months for recovery.
2.3. Social Instability Stress Procedure. Twomonths following
surgical procedure, rats were exposed to social instabil-
ity stress procedure consisting of alternate isolation and
crowding phases for 15 days based on previously described
model [35]. The experiment was started and ended with
isolation phase and each phase lasted 24 hours. For crowding
phase, eight rats were cohabited in one cage and each group
consisted of three males and five females. Male rats were
included to mimic normal social behaviour in human. Social
contacts between the group members were videotaped for
30 minutes at the beginning of each crowding phase. Biting
attacks and dominant postures while fighting for water or
food were recorded [36].
2.4. Forced Swimming Test. After the social instability stress
procedure, each rat was individually tested for depressive-
like behaviour using forced swimming test (FST). This test
was conducted between 10:00 and 17:00 hours in a brightly lit
room. Rats were individually placed in glass cylinders (40 cm
in height and 18 cm in diameter) filled with water up to 30 cm
in depth. The water level was purposely set higher than that
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in the procedure described by Porsolt and colleagues [37]
in order to prevent the rats from supporting themselves by
touching the bottom with their hind limbs or tail during the
swimming sessions.
Rats underwent two training sessions lasting 15 minutes
per session for two consecutive days. This was followed by a
5-minute test session 24 hours after the second session.Three
types of behaviour were scored: (1) immobility: floating in the
water, making only movements necessary to keep the head
above the water, (2) swimming: making active swimming
motions, and (3) struggling: making active attempts to escape
from the cylinder, including visual searching for escape routes
and diving [37]. After the test, rats were gently dried with
a towel and returned to their home cage. Three types of
behaviour were scored using a time-sampling technique that
has previously been shown to be both valid and reliable in
different behavioural studies [36]. Upon completion of FST,
rats were sacrificed immediately by rapid decapitation.
After sacrifice, ovariectomy was verified by visual inspec-
tion, uterine weights were determined and 10mL of trunk
blood samples was collected immediately. All blood samples
were left to clot for 2 hours prior to centrifugation for 15
minutes at 4000 rpm/minutes (EBA 21, Hettich GmbH&Co.
KG, Tuttlingen,Germany). Approximately 3mLof serumwas
collected and stored at –20∘C until assay. Brain from each
rat was quickly removed and carefully dissected in ice-cold
saline, and brain homogenates were prepared.
2.5. Estimation of Serum ACTH and Corticosterone Levels.
Serum adrenocorticotropic hormone (ACTH) and corti-
costerone levels were measured using specific ELISA kit
(Creative Diagnostics, Shirley, NY, USA) according to the
manufacturer’s instructions. Briefly, 100 𝜇L of serum sample
was added to each well followed by 100 𝜇L of enzyme-labelled
ACTH/corticosterone. The plate was incubated at 37∘C
for 90min. Following incubation, the wells were carefully
washed. Then, 100 𝜇L of biotin-antibody working solution
was added to eachwell and then incubated at 37∘C for 60min.
Following three washes, 100 𝜇L of horseradish peroxidase
(HRP) was added to each well and then incubated at 37∘C
for 30min. Next, 100𝜇L of 3,3󸀠,5,5󸀠-tetramethylbenzidine
(TMB) reagent was added to each well and incubated at room
temperature for 20min, which resulted in the development
of a color change. The colour change was then stopped with
the addition of 100 𝜇L of stop solution. The absorbance was
measured at 450 nm using a spectrophotometer (Thermo
Fisher Scientific Inc., Waltham, MA, USA).
2.6. Preparation of Brain Homogenates. The left hemisphere
was used to prepare brain homogenates (10%w/v) in ice-
cold 0.1M phosphate-buffered saline (PBS, pH 7.4).The brain
homogenates were centrifuged at 10,000×g for 10 minutes
and stored at −80∘C until assay.
2.7. Protein Concentration. Following homogenization, an
aliquot was removed from each sample to determine its
protein concentration using the Bradford method [38].
Briefly, protein concentration was quantified by comparing
the colorimetric intensity of the reaction product from each
sample with a series of protein standards. All BDNF levels
were normalized to their total protein concentration in the
sample in order to account for possible differences in protein
concentrations between samples. All data were expressed as
pg/𝜇g protein.
2.8. Measurement of BDNFConcentration. BDNF concentra-
tion was measured using commercially available ELISA kits
(Cusabio Biotech Co., Ltd., Newark, DE, USA) according to
the manufacturer’s instructions. Briefly, 100 𝜇L of sample or
standardwas added to eachwell and incubated for 90minutes
at 37.5∘C. The plate was washed four times with sample dilu-
ent. 100 𝜇Lof anti-BNDFantibodywas added to eachwell and
incubated for 60 minutes at 37.5∘C. After a series of washing,
100 𝜇L of HRP-avidin working solution was added to each
well and incubated for 30 minutes at 37.5∘C. Colorimetric
detection of peroxidase activity was achieved by adding 90𝜇L
of tetramethylbenzidine, resulting in blue colour change.The
reactions were terminated by adding 50 𝜇L of stop solution
to each well. Finally, the amount of BDNF was determined
using a spectrophotometer at 450 nm absorbance (Thermo
Fisher Scientific Inc., Waltham, MA, USA). The standard
curve represents a direct relationship between optical density
and BDNF level. BDNF concentration was expressed as pg
per mL.
2.9. Statistical Analysis. Data were analysed using Statistical
Package for the Social Sciences (SPSS) version 20. Two-way
analyses of variance (ANOVA) was utilized to examine the
effects of stress (stressed versus nonstressed) and surgery
(sham-operated versus OVX) conditions on all parameters
assessed in this study. One-way ANOVA followed by post-
hoc Tukey test was utilized to evaluate the effects of Tualang
honey and estradiol on all parameters assessed in this study.
Pearson’s correlation coefficient was used to test the corre-
lation between body weight and depressive-like behaviour.
Data were presented as the mean ± standard error of means
(SEM). Probability values of less than 5% (𝑃 < 0.05) were
considered statistically significant.
3. Results
3.1. Serum ACTH and Corticosterone Levels. The serum
ACTH and corticosterone levels were significantly higher in
stressed compared to nonstressed groups, that is, 56.952±1.89
versus 45.789 ± 1.200 pg/mL and 5661.905 ± 163.951 versus
4611.000 ± 169.430 pg/mL, respectively.
3.2. Depressive-Like Behaviour. Our two-wayANOVA results
showed significant main effects of surgery on all depressive-
like behaviour such as total swimming time (F(1, 36) =
67.49, 𝑃 < 0.001), immobility time (F(1, 36) = 140.36,
𝑃 < 0.001), and struggling time (F(1, 36) = 146.14, 𝑃 <
0.001). Meanwhile, the main effects of stress were signifi-
cant on some depressive-like behaviour such as immobility
time (F(1, 36) = 4.45, 𝑃 < 0.05) and struggling time
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(F(1, 36) = 4.87, 𝑃 < 0.05), but not on swimming time (F(1,
36) = 0.26, 𝑃 > 0.05).
In addition, results showed significant surgery and stress
interaction on all depressive-like behaviour such as immobil-
ity time (F(1, 36) = 14.41, 𝑃 < 0.01), struggling time (F(1,
36) = 6.13, 𝑃 < 0.05), and swimming time (F(1, 36) = 8.83,
𝑃 < 0.01). The results of two-way ANOVA are summarized
in Table 1.
The mean immobility time (F(5, 56) = 41.79, 𝑃 < 0.001),
struggling time (F(5, 56) = 55.61, 𝑃 < 0.001), and swimming
time (F(5, 56) = 19.74, 𝑃 < 0.001) were significantly different
among the groups as shown in Figure 1.The post-hoc analysis
revealed significant decrease in the mean immobility time
and significant increase in the mean swimming time of
stressed OVX treated with either E2 or Tualang honey
compared to untreated stressedOVX rats.The decrease in the
mean immobility time and increase in mean swimming time
of both treated groups were comparable to those of sham-
operated control rats. For the mean struggling time, there
was a significant increase in the stressed OVX treated with
either E2 or Tualang honey compared to untreated stressed or
nonstressed OVX but the values remained lower than those
of sham-operated control rats.
3.3. BDNF Concentration. There was a significant main effect
of surgery (F(1, 36) = 67.49, 𝑃 < 0.001), but not stress (F(1,
36) = 0.24,𝑃 > 0.05) on the BDNF concentration in the brain
homogenate. A significant stress and surgery interaction was
found on the BDNF concentration in the brain homogenate
(F(1, 36) = 8.83, 𝑃 < 0.05).
One-way ANOVA showed that the mean BDNF concen-
tration in the brain homogenate was significantly different
among the groups (F(5, 54) = 34.46, 𝑃 < 0.001). Both E2
and Tualang honey increased the mean BDNF concentration
in the brain homogenate of stressed OVX comparable to that
of sham-operated control rats as shown in Figure 2.
3.4. Correlation between Body Weight and Immobility Time,
Struggling Time, and Swimming Time. The body weight gain
was significantly higher in OVX rats compared to sham-
operated controls (59.60 ± 2.72 versus 24.20 ± 0.25 g). There
was no significant correlation between body weight gain and
depressive-like behaviour as shown in Table 2.
4. Discussion
Thepossibility of ovariectomy-inducedweight gain [39] asso-
ciated with longer immobility time and shorter struggling
time and swimming time was excluded by evaluating the cor-
relation between body weight and depressive-like behaviour
in the OVX rats using the Pearson product-moment cor-
relation. We found no significant correlation between these
variables. Although body weight in the ovariectomised group
was significantly greater than that in the sham-operated
group, this weight gain did not participate in the prolongation
of immobility or reduction in swimming time and struggling
time induced by ovariectomy. It was earlier noted that
the duration of immobility was increased while swimming
Table 1: Effects of surgery and stress on depressive-like behaviour.
Group Duration (seconds)
Swimming Immobility Struggling
Sham-operated
Nonstressed 131.70 ± 1.59 78.00 ± 2.0 94.41 ± 1.08
Stressed 133.30 ± 2.19 72.10 ± 2.50 94.12 ± 1.33
OVX
Nonstressed 120.28 ± 1.41 115.30 ± 1.54 51.10 ± 1.49
Stressed 109.70 ± 3.40∗ 18.91 ± 2.66 57.70 ± 3.28∗
Stress effect 𝑃 > 0.05 𝑃 < 0.05 𝑃 < 0.05
Surgery effect 𝑃 < 0.001 𝑃 < 0.001 𝑃 < 0.001
Stress × surgery
interaction 𝑃 < 0.05 𝑃 < 0.05 𝑃 < 0.05
Each value represents the mean ± SEM of 10 rats, significantly different from
nonstressed group at ∗𝑃 < 0.05.
Table 2: Correlation between the body weight gain and depressive-
like behaviour.
Depressive-like behaviour
(seconds)
Body weight gain
(gram)
Swimming −0.266
Struggling −0.253
Immobility 0.172
Body weight gain is the difference in body weight after surgical procedure
and at sacrifice. Each value represents the Pearson correlation coefficients
(𝑟). ∗Significant difference at 𝑃 < 0.05.
and struggling activities were decreased in ovariectomised
compared to non-ovariectomised rats [40].
We found that stressed ovariectomised rats displayed
more depressive-like behaviour compared to the other exper-
imental groups consistentwith findings fromprevious studies
[41–43]. Our results also revealed significant interaction
between stress and OVX on all parameters of depressive-
like behaviour supporting previous findings regarding inter-
actions between gonadal and adrenal hormones in hip-
pocampal function [44–52]. It was previously suggested
that deprivation of ovarian hormones for a long period of
time magnifies the effect of chronic unpredictable stress on
depressive-like behaviour in mice [43].
More interestingly, our data also showed that Tualang
honey or E2-treated stressed OVX rats had significant reduc-
tion in ACTH and corticosterone levels, as well as depressive-
like behaviour compared to those of untreated stressed OVX
rats. Estrogen has been shown to produce an antidepressive-
like effect during the forced swimming test in female rats
[53–57]. Furthermore, the link between estrogen and BDNF
expression and production has been proposed. Ovariectomy
decreases levels of BDNF mRNA, and estradiol treatment
reverses the effect in female rat hippocampus [19, 22, 58].
It was subsequently demonstrated that administration of
estradiol to gonadectomized male rat pups restores BDNF
expression in hippocampal pyramidal cells; an estrogen
response element (ERE) mechanism is implicated because
estrogen receptor-𝛼 (ER𝛼) colocalizes with BDNF [59].
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Figure 1: Effects of E2 andTualang honey treatments on depressive-like behaviour. (a) Swimming time (b) immobility time, and (c) struggling
time/5 minutes. Each column represents the mean ± SEM of 10 rats; a𝑃 < 0.05 compared with the stressed OVX group; b𝑃 < 0.05 compared
with the sham group.
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Figure 2: Effects of Tualang honey and E2 treatments on BDNF
concentrations. Each column represents the mean ± SEM of 10 rats;
a
𝑃 < 0.05 compared with the stressed OVX group.
Taken together, findings from these studies suggest that the
actions of estradiol in the hippocampus include regulation of
BDNF. Our findings of increased BDNF concentration and
reduced depressive-like behaviour following E2 treatment in
stressed OVX rats are further affirmation of this.
So far there is no report of the effects of honey on
depressive-like behaviour or on the BDNF concentration.
In the present study, apart from reducing depressive-like
behaviour, Tualang honey-treated stressed OVX rats also
increased the BDNF concentration comparable to those
of E2-treated stressed OVX rats. Since Tualang honey is
a phytoestrogen rich in flavonoids, it is possible that the
mechanisms of antidepressive-like actions are similar to
other phytochemical food rich in flavonoids such as green
tea, blueberry, and Ginkgo Biloba which have been shown
to increase hippocampal BDNF levels [60–64]. Recently,
another study reported that flavonoids-induced synthesis and
secretion of BDNF in cultured rat astrocytes are mediated by
the estrogen receptor [65], providing further indication of the
possible underlying mechanism.
Stress-induced reductions of BDNF may produce a risk
for depression, while restoration of HPA axis and BDNF
homeostasis following E2 and Tualang honey treatment may
be responsible for the improvement in mood [66–71]. The
ability of BDNF to reverse depressive-like behaviour in
6 The Scientific World Journal
the animal models may be attributed to increased monoam-
inergic activity within the central nervous system that in turn
compensates for the decreased levels of BDNF [72–74].
In conclusion, both stress hormones and estrogen defi-
ciency reduced the BDNF concentration and increased
depressive-like behaviour. The present study revealed that
treatment with either E2 or Tualang honey was able to reverse
these effects. It is possible that the antidepressive-like effects
of Tualang honey and E2 seen in our stressedOVX ratsmodel
act via restoration of HPA axis and enhancement of BDNF
concentration.
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